The Lancet Gastroenterology & Hepatology

Title Publication Date Language Citations
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study2022/06/01English5
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study2021/03/01English5
Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis2021/01/01English5
Differential diagnosis of inflammatory bowel disease: imitations and complications2018/09/01English5
Pancreaticobiliary maljunction and congenital biliary dilatation2017/08/01English5
Porto-sinusoidal vascular disease: proposal and description of a novel entity2019/05/01English5
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial2019/10/01English5
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study2020/03/01English5
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective2020/08/01English5
Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study2020/08/01English5
Inflammation and malnutrition in inflammatory bowel disease2023/06/01English5
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study2020/09/01English5
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study2020/11/01English5
Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder2020/10/01English5
The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease2021/01/01English5
Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial2021/08/01English5
SARS-CoV-2 in wastewater: potential health risk, but also data source2020/06/01English5
Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study2018/03/01English5
Pathogenesis and novel treatment options for non-alcoholic steatohepatitis2016/09/01English5
Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens2022/07/01English4
Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial2020/09/01English4
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial2022/03/01English4
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study2020/03/01English4
Correction to Lancet Gastroenterol Hepatol 2020; published online April 20. https://doi.org/10.1016/S2468-1253(20)30075-32020/08/01English4
Probiotics and COVID-19: one size does not fit all2020/07/01English4
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease2016/10/01English4
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial2017/12/01English4
Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency2017/09/01English4
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial2017/03/01English4
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium2017/02/01English4